Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun;33(6):e15115.
doi: 10.1111/exd.15115.

IL-4 and IL-13 are not involved in IL-31-induced itch-associated scratching behaviour in mice

Rana Kawai  1 , Nao Ichimasu  1 , Kazumoto Katagiri  1
Affiliations

IL-4 and IL-13 are not involved in IL-31-induced itch-associated scratching behaviour in mice

Rana Kawai et al. Exp Dermatol. 2024 Jun.

Abstract

Itchy skin or pruritus is a common cutaneous symptom that causes an urge to scratch, and the role of interleukins (IL) in itchy skin has been widely studied. IL-4 and IL-13 are known to induce chronic itch. Similarly, the direct role of IL-31 in inducing itch has been demonstrated in clinical situations such as atopic dermatitis and prurigo nodularis. Moreover, IL-4 receptor α antibodies (dupilumab) and IL-31 receptor A antibodies (nemolizumab) inhibit pruritus. However, the interplay between these ILs in pruritus remains unclear. Therefore, we investigated the reciprocal effects of these cytokines on pruritus in mice. The intradermal administration of IL-31 induced itch-associated scratching behaviour in a dose-dependent manner. Interestingly, the amount of IL-31 and IL-4/IL-13, co-administration or 30 min pre-administration of IL-4/IL-13 and intradermal or intravenous pre-administration of IL-4 did not affect IL-31-induced itch-associated scratching behaviour when it was observed for 30 min, 2 h, 24 h or 48 h. Pre-administration of neutralising antibodies against IL-4 and IL-13 also did not affect IL-31-induced itch-associated scratching behaviour. These results suggest that IL-31 can induce itching independently of IL-4 and IL-13 in vivo.

Keywords: IL‐13; IL‐31; IL‐4; pruritus.

PubMed Disclaimer

References

REFERENCES

    1. Oetjen LK, Mack MR, Feng J, et al. Sensory neurons Co‐opt classical immune signaling pathways to mediate chronic itch. Cell. 2017;171(1):217‐228 e13. doi:10.1016/j.cell.2017.08.006
    1. Beck LA, Thaci D, Hamilton JD, et al. Dupilumab treatment in adults with moderate‐to‐severe atopic dermatitis. N Engl J Med. 2014;371(2):130‐139. doi:10.1056/NEJMoa1314768
    1. Blauvelt A, de Bruin‐Weller M, Gooderham M, et al. Long‐term management of moderate‐to‐severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1‐year, randomised, double‐blinded, placebo‐controlled, phase 3 trial. Lancet. 2017;389(10086):2287‐2303. doi:10.1016/S0140-6736(17)31191-1
    1. Zhai LL, Savage KT, Qiu CC, Jin A, Valdes‐Rodriguez R, Mollanazar NK. Chronic pruritus responding to Dupilumab—a case series. Medicines (Basel). 2019;6(3):72. doi:10.3390/medicines6030072
    1. Campion M, Smith L, Gatault S, Metais C, Buddenkotte J, Steinhoff M. Interleukin‐4 and interleukin‐13 evoke scratching behaviour in mice. Exp Dermatol. 2019;28(12):1501‐1504. doi:10.1111/exd.14034